Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanoma. (2021)

First Author: Haas L
Attributed to:  Molecular origins of metastatic cancer phenotypes funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s43018-021-00221-9

PubMed Identifier: 35121945

Publication URI: http://europepmc.org/abstract/MED/35121945

Type: Journal Article/Review

Volume: 2

Parent Publication: Nature cancer

Issue: 7

ISSN: 2662-1347